Back to search

Belgium· BE-AMP-SAM501626-00

Qtern 5 mg - 10 mg

A saxagliptin and dapagliflozin product containing saxagliptin hydrochloride, registered in Belgium by AstraZeneca. The same ATC class is registered in 11 of our 19 countries.

ATC A10BD21

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedQtern 5 mg - 10 mgATCA10BD21REGISTER NO.BE-AMP-SAM501626-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Saxagliptin and dapagliflozin is registered in 11 of 19 countries.

Countries holding a registration under ATC A10BD21 (saxagliptin and dapagliflozin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Saxagliptin and dapagliflozin · ATC A10BD21

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Saxagliptin Hydrochloride
Manufacturer
AstraZeneca
Country
Belgium (BE)
ATC code
A10BD21
ATC class
Saxagliptin and dapagliflozin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Saxagliptin and dapagliflozin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All saxagliptin and dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • France · Saxagliptine Arrow, Saxagliptine Biogaran
  • United Kingdom (Northern Ireland) · Saxagliptin Sandoz, Saxagliptin Zydus Pharmaceuticals Uk
  • Hungary · Saxagliptin Pharos
  • Iceland · Onglyza
  • Liechtenstein · Onglyza
  • Malta · Saxagliptin Pharos
  • Netherlands · Saxagliptine Sandoz
  • Norway · Onglyza
  • Portugal · Saxagliptina Generis, Saxagliptina Generis Phar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f49cdfe3-689e-4f77-8269-ce90f991875a
GET /v1/drugs/f49cdfe3-689e-4f77-8269-ce90f991875a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Qtern 5 mg - 10 mg",
  "name_fr": "Qtern 5 mg - 10 mg",
  "name_nl": "Qtern 5 mg - 10 mg",
  "amp_code": "SAM501626-00",
  "strengths": [
    "5.0000",
    "10.0000",
    "40.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Saxagliptin Hydrochloride",
    "Saxagliptin",
    "Dapagliflozin Propanediol Monohydrate",
    "Dapagliflozin",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Saxagliptin and Dapagliflozin",
  "authorisation_numbers": [
    "EU/1/16/1108/001",
    "EU/1/16/1108/004",
    "EU/1/16/1108/002",
    "EU/1/16/1108/003"
  ]
}

See everything about saxagliptin and dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.